Delivery Order SPE2DB24D1205-SPE2DB25FDABR
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $5,593.77 to AmerisourceBergen Drug Corp for the supply of Calquence 100 mg tablets (60-count units). This competitively awarded, firm fixed-price contract with no set-aside designation has an ultimate completion date of September 16, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $5,593.77 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Calquence 100 mg tablets (60-count units). This non-set-aside contract is scheduled for completion by September 16, 2025, with performance at the contractor's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99...
- The Defense Logistics Agency awarded a $5,593.77 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Calquence 100 mg tablets (60-count units). The contract, which is expected to be completed by August 11, 2025, is non-set-aside and represents a competitively awarded transaction. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and healthcare solutions provider for federal medical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,593.77 for CALQUENCE 100 mg tablets (60-count units) on August 11, 2025, with completion expected by September 2, 2025. This firm fixed-price delivery order represents a non-competitive set-aside and is performed at the contractor's facility in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,593.77 to AmerisourceBergen Drug Corp for the supply of Calquence 100 mg tablets (60-count units) with a firm fixed price structure. This non-set-aside competitive award was announced on August 18, 2025, with an ultimate completion date of September 9, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $5,593.77 to AmerisourceBergen Drug Corp for Calquence 100 mg tablets (60-count package) on July 28, 2025, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Calquence is a prescription oncology medication used in the treatment of certain blood cancers,...
- The Defense Logistics Agency awarded a $5,593.77 firm fixed price delivery order to AmerisourceBergen Drug Corp for Calquence 100 mg tablets (60-count units) on September 3, 2025, with an ultimate completion date of September 24, 2025. The contract is unclassified as a set-aside and will be performed at the company's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Calquence 100 mg tablets (60-count units) under a firm fixed-price contract valued at $5,593.77. The contract was competitively awarded without set-aside designation and is scheduled for completion by July 2, 2025. AmerisourceBergen will perform the delivery order from its corporate office location in Conshohocken, Pennsylvania. This delivery order represents a discrete fulfillment against...
- The Defense Logistics Agency awarded a $11,187.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Calquence 100 mg tablets (60-count) on September 11, 2025, with an ultimate completion date of October 2, 2025. The contract, which is not set-aside, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single transaction under AmerisourceBergen's larger indefinite delivery contract vehicle with the DLA....
- The Defense Logistics Agency awarded a $5,593.77 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Calquence 100 mg tablets (60-count units). This non-set-aside, firm fixed-price delivery order is scheduled for completion by August 18, 2025, with performance at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FDABRDelivery Order
The Defense Logistics Agency has awarded a delivery order valued at $5,593.77 to AmerisourceBergen Drug Corp for the supply of Calquence 100 mg tablets (60-count units). This competitive, non-set-aside contract award is classified as a firm fixed price delivery order with an ultimate completion date of September 24, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026, which serves as the primary vehicle for comprehensive global pharmaceutical support to military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, has established itself as a critical vendor for federal medical procurement through its extensive portfolio of competitively awarded contracts with the Defense Logistics Agency. The company's IDC encompasses a wide spectrum of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains, supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide. Calquence is an oncology medication used in the treatment of certain blood cancers, reflecting the breadth of specialized pharmaceutical support provided through this contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.6k | 9/3/25 |